The Biden administration announced Friday it is allocating $1.7 billion to fight coronavirus variants, as the virus continues to mutate into more deadly
Lynn Schenk
Lynn Schenk, Board Member
Lynn Schenk is an attorney and senior corporate advisor. She serves on the Board of Directors of Cambridge, Mass. based Biogen Idec,(NASDAQ BIIB), the Board of Trustees of the Scripps Research Institute, and the Board of the San Diego Consortium for Regenerative Medicine. In 2006, she completed her term as a commissioner of the California Medical Assistance Commission.
Ms. Schenk served as Chief of Staff to California Governor Gray Davis from 1999 to 2003. As Chief of Staff to the Governor, she oversaw the day to day operations of state government through the 12 Cabinet agencies and more than 75 departments and offices. She managed the Governor’s office staff of about 200 and had the homeland security office, the National Guard, and the Office of Emergency Services reporting directly to her. She was the Governor’s chief executive and top policy advisor.
U.S. to spend $1.7 billion on fighting variants
Tyler Pager and Joel Achenbach, The Washington Post
April 16, 2021
FacebookTwitterEmail
A COVID-19 particle is pictured in this image provided by the CDC. A study published in the Lanced medical journal examined the case of a man who became infected with two different variants of the SARS-CoV-2 virus in less than two months. Variant strains of the coronavirus now make up about half of all cases in the country. (Centers for Disease Control and Prevention)Cdc/TNS
WASHINGTON - The Biden administration announced Friday it is allocating $1.7 billion to fight coronavirus variants, as the virus continues to mutate into more deadly and infectious forms.
RIO DE JANEIRO, BRAZIL - Understanding the behavior of SARS-CoV-2 and how its mutations test the management of the pandemic and even the efficacy of the vaccines developed in record time is undoubtedly of great interest to the women and men of science.
Prestigious cardiologist Eric J. Topol is a professor of molecular medicine at the Scripps Research Institute in California and on his Twitter account he highlighted two articles published in Science journal on Covid-19 in Brazil, which document what triggered the emergence of the P1 variant in Manaus and analyze its high transmissibility, potential increase in . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here
Molecular assembly line could speed design of new drugs futurity.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from futurity.org Daily Mail and Mail on Sunday newspapers.